封面
市场调查报告书
商品编码
1594565

整形手术市场:按手术和应用分类 - 2025-2030 年全球预测

Oculoplastic Surgery Market by Procedure (Brow Lift & Forehead Lift, Eyelid Surgery, Face Lift Surgery), End-Use (Ambulatory Surgical Centers, Hospitals & Clinics) - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年整形手术市值为103.8亿美元,预计到2024年将达到113.5亿美元,复合年增长率为9.40%,到2030年将达到194.8亿美元。

整形手术是眼科的一个专业,包括涉及眼眶、眼睑、泪管和脸部的外科手术。它在医疗和美容领域发挥着重要作用,可解决上眼睑下垂(眼睑下垂)、肿瘤和创伤等问题。人口老化、美学意识增强和眼部疾病发病率增加等因素推动了此类手术的需求。最终使用者主要是医院、眼科诊所和门诊手术中心。整形手术市场的成长受到微创技术和人工智慧整合等技术进步的显着影响,以改善手术结果。此外,医疗保健支出的增加和门诊病人手术需求的增加也促进了市场的扩张。市场的机会在于对美容手术不断增长的需求以及新型手术器械和技术的发展。为了利用这些机会,公司应该专注于先进手术系统和人工智慧诊断工具的研发。然而,挑战依然存在,包括高昂的手术和设备成本、严格的监管要求,以及与手术相关的潜在併发症,可能会让一些患者望而却步。此外,需要提高患者对整形手术的益处和安全性的认识,特别是在发展中地区。市场创新可以专注于开拓具有成本效益的手术解决方案和增强患者照护模式。医疗科技公司和医疗保健提供者之间的合作可以开闢新的成长途径,同时确保眼部整形治疗的品质和可及性。市场仍然竞争激烈,老牌企业和新参与企业都在追求技术领先和以患者为中心的解决方案,这表明不断发展的市场已经成熟,适合创新和策略性投资。建立强有力的教育计划和伙伴关係可以解决现有的知识差距并促进这些程序的广泛采用。

主要市场统计
基准年[2023] 103.8亿美元
预测年份 [2024] 113.5亿美元
预测年份 [2030] 194.8亿美元
复合年增长率(%) 9.40%

市场动态:揭示快速发展的整形手术市场的关键市场洞察

供需的动态交互作用正在改变整形手术市场。透过了解这些不断变化的市场动态,公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险,同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 老年人口增加及眼部相关疾病盛行率增加
    • 全球整形外科医生数量增加
    • 由于老龄化导致整形手术增加
  • 市场限制因素
    • 缺乏报销政策
  • 市场机会
    • 采用创新的微创技术、新手术和新技术
    • 双眼皮美容手术的发展
  • 市场挑战
    • 眼科整形手术的风险管理问题

波特的五力:驾驭整形手术市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势,解决弱点并避免潜在的挑战,从而确保更强大的市场地位。

PESTLE分析:了解整形手术市场的外部影响

外部宏观环境因素在塑造整形手术市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素,公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化,并为他们做出积极主动的决策做好准备。

市场占有率分析 了解整形手术市场的竞争状况

整形手术市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势,为供应商提供了製定策略决策所需的洞察力,使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵整形手术市场供应商绩效评估

FPNV 定位矩阵是评估整形手术市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商,从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商,并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了整形手术市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说,整形手术市场的策略分析至关重要。透过审查关键资源、能力和绩效指标,公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战,利用新的商机,并取得长期成功。

本报告对市场进行了全面分析,涵盖关键重点领域:

1. 市场渗透率:对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓:辨识新兴市场的成长机会,评估现有领域的扩张潜力,并提供未来成长的策略蓝图。

3. 市场多元化:分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报:全面分析竞争格局,检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新:重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题,以帮助相关人员做出明智的决策:

1.目前的市场规模和未来的成长预测是多少?

2. 哪些产品、区隔市场和地区提供最佳投资机会?

3.塑造市场的主要技术趋势和监管影响是什么?

4.主要厂商的市场占有率和竞争地位如何?

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么?

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 老年人口增加,眼部疾病发生率增加
      • 世界各地整形外科医生的数量正在增加。
      • 由于老龄化导致整形手术增加
    • 抑制因素
      • 缺乏退费政策
    • 机会
      • 采用创新的微创技术、新手术和新技术
      • 双眼皮美容手术的发展
    • 任务
      • 眼科整形手术的风险管理问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章整形手术市场(依程序)

  • 提眉和额头提升
  • 眼睑手术
  • 拉皮手术
  • 小儿科整形手术

第七章整形手术市场:依最终用途

  • 门诊手术中心
  • 医院/诊所

第八章北美及南美整形手术市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区整形手术市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东、非洲整形手术市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵,2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Antibe Therapeutics Inc.
  • B. Braun Melsungen AG
  • Blink Medical Ltd.
  • BMT Medizintechnik GmbH
  • Bolton Surgical Ltd.
  • Integra Life Science
  • Karlz Storz
  • Sklar Surgical Instruments
  • Stanford Health Care
  • TEKNO_MEDICAL Optik-Chirunge GmbH
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-433C4187C561

The Oculoplastic Surgery Market was valued at USD 10.38 billion in 2023, expected to reach USD 11.35 billion in 2024, and is projected to grow at a CAGR of 9.40%, to USD 19.48 billion by 2030.

Oculoplastic surgery, a specialized branch of ophthalmology, encompasses surgical procedures related to the eye socket, eyelids, tear ducts, and the face. It plays a critical role in both medical and cosmetic domains, addressing issues like ptosis (drooping eyelids), tumors, and trauma. The necessity for such surgeries is driven by factors such as aging populations, increasing aesthetic awareness, and rising incidences of ophthalmic disorders. End users primarily include hospitals, ophthalmic clinics, and ambulatory surgical centers. The market growth for oculoplastic surgery is significantly influenced by technological advancements, including minimally invasive techniques and the integration of artificial intelligence for improved surgical outcomes. Moreover, the growing healthcare expenditure and increasing demand for outpatient procedures contribute to market expansion. Opportunities within the market lie in the rising demand for aesthetic procedures and the development of novel surgical instruments and techniques. Companies should focus on research and development for advanced surgical systems and AI-driven diagnostic tools to capitalize on these opportunities. However, challenges persist, such as high procedural and equipment costs, stringent regulatory requirements, and potential complications associated with surgeries that may deter some patients. Furthermore, there is a need to enhance patient awareness about the benefits and safety of oculoplastic procedures, particularly in developing regions. Market innovation can hone in on the development of cost-effective surgical solutions and enhanced patient care models. Collaborations between medical technology firms and healthcare providers can spark new avenues for growth, ensuring quality and accessibility in oculoplastic care. The market remains competitive, with major players and new entrants striving for technological leadership and patient-centric solutions, suggesting an ever-evolving landscape ripe for innovation and strategic investments. Establishing strong educational programs and partnerships can address existing knowledge gaps and fuel the broad adoption of these surgeries.

KEY MARKET STATISTICS
Base Year [2023] USD 10.38 billion
Estimated Year [2024] USD 11.35 billion
Forecast Year [2030] USD 19.48 billion
CAGR (%) 9.40%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Oculoplastic Surgery Market

The Oculoplastic Surgery Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in geriatric population and increasing prevalence of eye related disorder
    • Rising number of plastic surgeons across the globe
    • Growing number of age-related oculoplastic surgeries
  • Market Restraints
    • Lack of reimbursement policies
  • Market Opportunities
    • Adoption of innovative minimally-invasive techniques, novel procedures and newer technologies
    • Development in aesthetic eyelid surgery
  • Market Challenges
    • Risk management issues in ophthalmic plastic surgery

Porter's Five Forces: A Strategic Tool for Navigating the Oculoplastic Surgery Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Oculoplastic Surgery Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Oculoplastic Surgery Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Oculoplastic Surgery Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Oculoplastic Surgery Market

A detailed market share analysis in the Oculoplastic Surgery Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Oculoplastic Surgery Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Oculoplastic Surgery Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Oculoplastic Surgery Market

A strategic analysis of the Oculoplastic Surgery Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Oculoplastic Surgery Market, highlighting leading vendors and their innovative profiles. These include Antibe Therapeutics Inc., B. Braun Melsungen AG, Blink Medical Ltd., BMT Medizintechnik GmbH, Bolton Surgical Ltd., Integra Life Science, Karlz Storz, Sklar Surgical Instruments, Stanford Health Care, TEKNO_MEDICAL Optik-Chirunge GmbH, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Oculoplastic Surgery Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Procedure, market is studied across Brow Lift & Forehead Lift, Eyelid Surgery, Face Lift Surgery, and Pediatric Oculoplastic Surgery.
  • Based on End-Use, market is studied across Ambulatory Surgical Centers and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in geriatric population and increasing prevalence of eye related disorder
      • 5.1.1.2. Rising number of plastic surgeons across the globe
      • 5.1.1.3. Growing number of age-related oculoplastic surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of reimbursement policies
    • 5.1.3. Opportunities
      • 5.1.3.1. Adoption of innovative minimally-invasive techniques, novel procedures and newer technologies
      • 5.1.3.2. Development in aesthetic eyelid surgery
    • 5.1.4. Challenges
      • 5.1.4.1. Risk management issues in ophthalmic plastic surgery
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Oculoplastic Surgery Market, by Procedure

  • 6.1. Introduction
  • 6.2. Brow Lift & Forehead Lift
  • 6.3. Eyelid Surgery
  • 6.4. Face Lift Surgery
  • 6.5. Pediatric Oculoplastic Surgery

7. Oculoplastic Surgery Market, by End-Use

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Hospitals & Clinics

8. Americas Oculoplastic Surgery Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Oculoplastic Surgery Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Oculoplastic Surgery Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Antibe Therapeutics Inc.
  • 2. B. Braun Melsungen AG
  • 3. Blink Medical Ltd.
  • 4. BMT Medizintechnik GmbH
  • 5. Bolton Surgical Ltd.
  • 6. Integra Life Science
  • 7. Karlz Storz
  • 8. Sklar Surgical Instruments
  • 9. Stanford Health Care
  • 10. TEKNO_MEDICAL Optik-Chirunge GmbH
  • 11. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. OCULOPLASTIC SURGERY MARKET RESEARCH PROCESS
  • FIGURE 2. OCULOPLASTIC SURGERY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL OCULOPLASTIC SURGERY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL OCULOPLASTIC SURGERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL OCULOPLASTIC SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS OCULOPLASTIC SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS OCULOPLASTIC SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES OCULOPLASTIC SURGERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES OCULOPLASTIC SURGERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC OCULOPLASTIC SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC OCULOPLASTIC SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA OCULOPLASTIC SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA OCULOPLASTIC SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. OCULOPLASTIC SURGERY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. OCULOPLASTIC SURGERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. OCULOPLASTIC SURGERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL OCULOPLASTIC SURGERY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL OCULOPLASTIC SURGERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL OCULOPLASTIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. OCULOPLASTIC SURGERY MARKET DYNAMICS
  • TABLE 7. GLOBAL OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL OCULOPLASTIC SURGERY MARKET SIZE, BY BROW LIFT & FOREHEAD LIFT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL OCULOPLASTIC SURGERY MARKET SIZE, BY EYELID SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL OCULOPLASTIC SURGERY MARKET SIZE, BY FACE LIFT SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL OCULOPLASTIC SURGERY MARKET SIZE, BY PEDIATRIC OCULOPLASTIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL OCULOPLASTIC SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL OCULOPLASTIC SURGERY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS OCULOPLASTIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES OCULOPLASTIC SURGERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC OCULOPLASTIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA OCULOPLASTIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM OCULOPLASTIC SURGERY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM OCULOPLASTIC SURGERY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. OCULOPLASTIC SURGERY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. OCULOPLASTIC SURGERY MARKET, FPNV POSITIONING MATRIX, 2023